Letter to the EditorCombination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy
References (8)
Clin Gastroenterol Hepatol
(2018)Ann Intern Med
(2014)Inflamm Bowel Dis
(2007)Am J Gastroenterol
(2015)
There are more references available in the full text version of this article.
Cited by (0)
Conflicts of interest This author discloses the following: Laurent Peyrin-Biroulet has received honoraria from Pfizer and Takeda. The remaining authors disclose no conflicts.
© 2018 by the AGA Institute